Free Trial
NASDAQ:NERV

Minerva Neurosciences (NERV) Stock Price, News & Analysis

Minerva Neurosciences logo
$1.64 -0.01 (-0.61%)
As of 04:00 PM Eastern

About Minerva Neurosciences Stock (NASDAQ:NERV)

Key Stats

Today's Range
$1.59
$1.79
50-Day Range
$1.38
$1.85
52-Week Range
$1.15
$3.50
Volume
9,252 shs
Average Volume
22,867 shs
Market Capitalization
$11.54 million
P/E Ratio
2.00
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Hold

Company Overview

Minerva Neurosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
79th Percentile Overall Score

NERV MarketRank™: 

Minerva Neurosciences scored higher than 79% of companies evaluated by MarketBeat, and ranked 208th out of 913 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Minerva Neurosciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Minerva Neurosciences has received no research coverage in the past 90 days.

  • Read more about Minerva Neurosciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Minerva Neurosciences are expected to decrease in the coming year, from ($0.30) to ($2.68) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Minerva Neurosciences is 2.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.73.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Minerva Neurosciences is 2.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.42.

  • Read more about Minerva Neurosciences' valuation and earnings.
  • Percentage of Shares Shorted

    0.58% of the float of Minerva Neurosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Minerva Neurosciences has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Minerva Neurosciences has recently decreased by 2.49%, indicating that investor sentiment is improving.
  • Dividend Yield

    Minerva Neurosciences does not currently pay a dividend.

  • Dividend Growth

    Minerva Neurosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.58% of the float of Minerva Neurosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Minerva Neurosciences has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Minerva Neurosciences has recently decreased by 2.49%, indicating that investor sentiment is improving.
  • News Sentiment

    Minerva Neurosciences has a news sentiment score of -0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Minerva Neurosciences this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Minerva Neurosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 8.60% of the stock of Minerva Neurosciences is held by insiders.

  • Percentage Held by Institutions

    Only 34.56% of the stock of Minerva Neurosciences is held by institutions.

  • Read more about Minerva Neurosciences' insider trading history.
Receive NERV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Minerva Neurosciences and its competitors with MarketBeat's FREE daily newsletter.

NERV Stock News Headlines

Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
Minerva Neurosciences Inc.
Minerva Neurosciences regains Nasdaq compliance
See More Headlines

NERV Stock Analysis - Frequently Asked Questions

Minerva Neurosciences' stock was trading at $2.22 on January 1st, 2025. Since then, NERV stock has decreased by 26.1% and is now trading at $1.64.

Minerva Neurosciences, Inc (NASDAQ:NERV) announced its quarterly earnings data on Tuesday, May, 13th. The biopharmaceutical company reported ($0.50) earnings per share for the quarter, topping analysts' consensus estimates of ($1.07) by $0.57.

Shares of Minerva Neurosciences reverse split on the morning of Tuesday, June 21st 2022.The 1-8 reverse split was announced on Tuesday, June 21st 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Shares of NERV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Minerva Neurosciences investors own include NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Meta Platforms (META), NIO (NIO), TherapeuticsMD (TXMD), Inovio Pharmaceuticals (INO) and VBI Vaccines (VBIV).

Company Calendar

Last Earnings
5/13/2025
Today
7/07/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NERV
Fax
N/A
Employees
9
Year Founded
2007

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$5.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+188.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
2.12
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.44 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.22 per share
Price / Cash Flow
7.90
Book Value
($3.67) per share
Price / Book
-0.47

Miscellaneous

Free Float
N/A
Market Cap
$11.54 million
Optionable
Not Optionable
Beta
-0.34

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:NERV) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners